Amgen Inc. buy phonebroker
Start price
29.04.21
/
40%
€196.62
Target price
29.04.22
€217.00
Performance (%)
-3.11%
End price
23.08.21
€190.50
Summary
This prediction ended on 23.08.21 with a price of €190.50. With a performance of -3.11%, the BUY prediction for Amgen Inc. by phonebroker closed slightly in the red. Dividends of €2.95 are taken into consideration when calculating the performance. phonebroker has 40% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Amgen Inc. | 3.747% | 3.747% | 26.709% | 53.621% |
| iShares Core DAX® | 2,99 % | 3,22 % | 4,27 % | 53,70 % |
| iShares Nasdaq 100 | -1,58 % | -3,17 % | 24,75 % | 76,70 % |
| iShares Nikkei 225® | -2,25 % | -9,92 % | 43,52 % | 60,79 % |
| iShares S&P 500 | -0,01 % | 1,64 % | 20,97 % | 62,81 % |
Comments by phonebroker for this prediction
In the thread Amgen Inc. diskutieren
Buy Amgen Inc.
Kursziel gesetzt auf 217,0